364 related articles for article (PubMed ID: 30441769)
1. Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid.
Ceci C; Lacal PM; Tentori L; De Martino MG; Miano R; Graziani G
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30441769
[TBL] [Abstract][Full Text] [Related]
2. Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth.
Ceci C; Tentori L; Atzori MG; Lacal PM; Bonanno E; Scimeca M; Cicconi R; Mattei M; de Martino MG; Vespasiani G; Miano R; Graziani G
Nutrients; 2016 Nov; 8(11):. PubMed ID: 27879653
[TBL] [Abstract][Full Text] [Related]
3. Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer.
Wang N; Wang ZY; Mo SL; Loo TY; Wang DM; Luo HB; Yang DP; Chen YL; Shen JG; Chen JP
Breast Cancer Res Treat; 2012 Aug; 134(3):943-55. PubMed ID: 22350787
[TBL] [Abstract][Full Text] [Related]
4. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
Arulmozhi V; Pandian K; Mirunalini S
Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
[TBL] [Abstract][Full Text] [Related]
5. Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers.
Ceci C; Graziani G; Faraoni I; Cacciotti I
Nanotechnology; 2020 Sep; 31(38):382001. PubMed ID: 32380485
[TBL] [Abstract][Full Text] [Related]
6. In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells.
Qiu Z; Zhou B; Jin L; Yu H; Liu L; Liu Y; Qin C; Xie S; Zhu F
Food Chem Toxicol; 2013 Sep; 59():428-37. PubMed ID: 23811531
[TBL] [Abstract][Full Text] [Related]
7. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice.
Seeram NP; Adams LS; Henning SM; Niu Y; Zhang Y; Nair MG; Heber D
J Nutr Biochem; 2005 Jun; 16(6):360-7. PubMed ID: 15936648
[TBL] [Abstract][Full Text] [Related]
8. Cyclodextrin-based nanosponge for improvement of solubility and oral bioavailability of Ellagic acid.
Mady FM; Ibrahim SR
Pak J Pharm Sci; 2018 Sep; 31(5(Supplementary)):2069-2076. PubMed ID: 30393214
[TBL] [Abstract][Full Text] [Related]
9. Ellagic acid a multi-target bioactive compound for drug discovery in CNS? A narrative review.
Alfei S; Turrini F; Catena S; Zunin P; Grilli M; Pittaluga AM; Boggia R
Eur J Med Chem; 2019 Dec; 183():111724. PubMed ID: 31563012
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles.
Mady FM; Shaker MA
Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891
[TBL] [Abstract][Full Text] [Related]
11. Ellagic acid inhibits human glioblastoma growth in vitro and in vivo.
Wang D; Chen Q; Tan Y; Liu B; Liu C
Oncol Rep; 2017 Feb; 37(2):1084-1092. PubMed ID: 28035411
[TBL] [Abstract][Full Text] [Related]
12. MDM2 as a target for ellagic acid‑mediated suppression of prostate cancer cells in vitro.
Mohammed Saleem YI; Selim MI
Oncol Rep; 2020 Sep; 44(3):1255-1265. PubMed ID: 32705219
[TBL] [Abstract][Full Text] [Related]
13. Multiple effects of ellagic acid on human colorectal carcinoma cells identified by gene expression profile analysis.
Zhao J; Li G; Bo W; Zhou Y; Dang S; Wei J; Li X; Liu M
Int J Oncol; 2017 Feb; 50(2):613-621. PubMed ID: 28101576
[TBL] [Abstract][Full Text] [Related]
14. Ellagic acid inhibits migration and invasion by prostate cancer cell lines.
Pitchakarn P; Chewonarin T; Ogawa K; Suzuki S; Asamoto M; Takahashi S; Shirai T; Limtrakul P
Asian Pac J Cancer Prev; 2013; 14(5):2859-63. PubMed ID: 23803044
[TBL] [Abstract][Full Text] [Related]
15. Effects of ellagic acid by oral administration on distribution and metabolism of 2-aminofluorene in Sprague-Dawley rats.
Ho CC; Lai YS; Wang DY; Chen YS; Lee JH; Tang NI; Chung JG
In Vivo; 2005; 19(1):143-56. PubMed ID: 15796167
[TBL] [Abstract][Full Text] [Related]
16. Ellagic acid induces esophageal squamous cell carcinoma cell apoptosis by modulating SHP-1/STAT3 signaling.
Xu YY; Wang WW; Huang J; Zhu WG
Kaohsiung J Med Sci; 2020 Sep; 36(9):699-704. PubMed ID: 32374927
[TBL] [Abstract][Full Text] [Related]
17. Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives.
Jaman MS; Sayeed MA
Breast Cancer; 2018 Sep; 25(5):517-528. PubMed ID: 29725861
[TBL] [Abstract][Full Text] [Related]
18. Ellagic acid and human cancers: a systems pharmacology and docking study to identify principal hub genes and main mechanisms of action.
Cheshomi H; Bahrami AR; Matin MM
Mol Divers; 2021 Feb; 25(1):333-349. PubMed ID: 32410114
[TBL] [Abstract][Full Text] [Related]
19. Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms.
Kang I; Buckner T; Shay NF; Gu L; Chung S
Adv Nutr; 2016 Sep; 7(5):961-72. PubMed ID: 27633111
[TBL] [Abstract][Full Text] [Related]
20. Ellagic acid, a component of pomegranate fruit juice, suppresses androgen-dependent prostate carcinogenesis via induction of apoptosis.
Naiki-Ito A; Chewonarin T; Tang M; Pitchakarn P; Kuno T; Ogawa K; Asamoto M; Shirai T; Takahashi S
Prostate; 2015 Feb; 75(2):151-60. PubMed ID: 25284475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
